Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine
European Journal of Immunology · 2023
DOI: 10.1002/eji.202048980 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2023. Verfasst von Li Hui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Second Xiangya Hospital of Central South University, Changsha, Hunan, P. R. China. Hauptthemen laut MEDLINE: Autoimmune Diseases, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 208 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Epigenetics, as a discipline that aims to explain the differential expression of phenotypes arising from the same gene sequence and the heritability of epigenetic expression, has received much attention in medicine. Epigenetic mechanisms are constantly being discovered, including DNA methylation, histone modifications, noncoding RNAs and m6A. The immune system mainly achieves an immune response through the differentiation and functional expression of immune cells, in which epigenetic modification will have an important impact. Because of immune infiltration in the tumor microenvironment, immunotherapy has become a research hotspot in tumor therapy. Epigenetics plays an important role in autoimmune diseases and cancers through immunology. An increasing number of drugs targeting epigenetic mechanisms, such as DNA methyltransferase inhibitors, histone deacetylase inhibitors, and drug combinations, are being evaluated in clinical trials for the treatment of various cancers (including leukemia and osteosarcoma) and autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis). This review summarizes the progress of epigenetic regulation for cancers and autoimmune diseases to date, shedding light on potential therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Second Xiangya Hospital of Central South University, Changsha, Hunan, P. R. China.
- Hunan Key Laboratory of Medical Epigenetics, Department of Dermatology, Second Xiangya Hospital of Central South University, Changsha, Hunan, P. R. China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hui, L., Ziyue, Z., Chao, L., Bin, Y., Aoyu, L., & Haijing, W. (2023). Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine. European Journal of Immunology. https://doi.org/10.1002/eji.202048980
Vancouver
Hui L, Ziyue Z, Chao L, Bin Y, Aoyu L, Haijing W. Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine. European Journal of Immunology. 2023. doi:10.1002/eji.202048980
BibTeX
@article{Hui2023,
author = {Hui, Li and Ziyue, Zhao and Chao, Liu and Bin, Yu and Aoyu, Li and Haijing, Wu},
title = {Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine},
journal = {European Journal of Immunology},
year = {2023},
doi = {10.1002/eji.202048980}
}
EUVIMED